One in three Americans suffer from hypertension, the precursor to myocardial infarction and stroke. Anticoagulants such as Xarelto (rivaroxaban) thin the blood to relieve the pressure on the heart as well as to prevent the formation of blood clots that can cause deep vein thrombosis (DVT), pulmonary embolism, and strokes.

One study shows that Xarelto is effective in reducing the number of hospital visits for DVT patients by as much as 27% compared to patients on other blood thinning medication. Xarelto is also efficacious in the management of hypertension in many patients because it has no dietary restrictions and there is no need for constant monitoring, such as in the case of warfarin, which is the standard treatment for hypertension.

There are ongoing efforts by development partners Janssen Pharmaceuticals and Bayer Healthcare to expand the use of Xarelto by conducting numerous clinical trials. The most current one is called NAVIGATE-ESUS, which will be using data from 7,000 patients who have recently suffered ESUS (embolic stroke with an unknown source). The aim of the study is to see how well Xarelto will work against the standard aspirin in preventing a second stroke event. If the clinical trial shows favorable results, Xarelto will be up again before the Food and Drug Administration (FDA) for expanded clinical approval. And more money, of course.

However, Xarelto is also giving headaches to the Janssen and Bayer legal teams because it works too well. According to the website of the lawyers at Williams Kherkher, some patients on Xarelto experience severe and sometimes fatal internal bleeding events for which there is no known antidote. More than 80 lawsuits have been filed against Janssen and Bayer and is currently consolidated in Philadelphia under multidistrict litigation. The claims are sufficiently similar: patients were inadequately warned about the bleeding dangers of Xarelto.

If you have suffered serious harm from taking Xarelto, you could be eligible to join the ranks of the plaintiffs. Consult with a Xarelto lawyer in your state for more information about the liability of these drug companies.